study. Mr. Deily said the results of these studies will be reported to the committee at the October
meeting. Rep. Davis added that an audit in this area will also be available at that time.
4. Genetic Testing Privacy Act
Chair Stephens announced that the committee would continue it's study of 1998 H.B. 271, Genetic Testing Privacy Act, focusing on health insurance and informed consent.
Mr. Jeff Gabardi, Health Insurance Association of America (HIAA), introduced Mr. L.
Carl Volpe, Vice President, Health Policy and Analysis, Wellpoint Health Networks, and
distributed the handout HIAA, Testimony of L. Carl Volpe, PhD. Mr. Volpe said that medical advances have allowed genetic characteristics to be included with age, gender, weight, smoking,
occupation, and health status as risk selection and risk classification factors. He said the addition
of genetic information as a risk factor has increased fears about the denial of health insurance
based on genetic discrimination. Mr. Volpe noted that the health insurance industry has defined
genetic tests as those that link specific health conditions to specific genes or gene products.
Mr. Volpe explained that the Health Insurance Portability and Accountability Act of
1996 (HIPAA) prohibits insurers offering group coverage from using genetic testing information
in determining initial eligibility or renewal of coverage. However, insurers may use the
information as a basis for raising rates. He said that regarding the individual market, genetic
information cannot be used to deny renewal of coverage, however, the rate may be increased. He
quoted a recent survey of the members of HIAA which showed that none of its members requires
a genetic test as a condition of application for health coverage or renewal. He noted that federal
law is silent on the use of genetic information in the initial coverage decision in the individual
market because of the issue of risk spreading.
Mr. Volpe said 30 states have either guarantee issue or specific prohibitions on the use of
genetic testing at the individual level. He identified the following provisions in state legislation:
(1) the definition of a genetic test is very narrow; and (2) the inclusion of "safe harbors"
excluding certain routine tests from the genetic test prohibition. He cautioned that legislation
aimed at improving access may increase costs, thereby decreasing access to individuals. He
concluded that based on industry practice and current federal and state laws, the industry believes
that no additional legislation to limit the use of genetic testing in health insurance risk
assessment is necessary.
Dr. David Viskochil, clinical geneticist, University of Utah, and a member of the Health
Department's Genetics Advisory Committee, reported regarding concerns with research issues in
H.B. 271. He said the advisory committee is in complete agreement with Section 26-40-112,
which contains additional guidelines for research studies. On the other hand, he believes Section
26-40-114 would be difficult to implement because it requires retroactive consent. He explained
that established Institutional Review Boards (IRBs), already cover the guidelines included in the bill.
He recommended that IRBs continue to be used for research. Chair Stephens asked how
confidentiality can be protected without retroactive consent. Dr. Viskochil responded that
participants are asked to give consent for use of their samples for other purposes in the initial
consent. He said another option is to make the samples anonymous. He said the key issue is to
enforce the protocols.
5. Other Business
Report on the advisability of Utah Valley State College leasing Developmental Center land _ Chair Stephens informed the committee that S.B. 177, Review of Lease or Purchase of Utah State Developmental Center Land By Utah Valley State College, requires the Board of Regents to review the advisability of leasing developmental center land by Utah Valley State
college and report its findings, conclusions, and recommendations to the Health and Human
Services Interim Committee, the Education Interim Committee and the Executive Appropriations
Interim Committee by July 1, 1998.
Mr. Fred Hunsaker, staff to the Board of Regents, reported that the Legislature directed
the Board of Regents to prepare a report addressing the following issues: (1) the need for an
additional campus of Utah Valley State College; (2) the advisability of acquiring a portion of
land associated with the Utah State Developmental Center near American Fork for such a
campus; and (3) financial considerations for acquiring this site if it is deemed advisable. He
reported that the study determined that there is a need for an additional campus in Utah County
and that the developmental center land is a desirable location. Mr. Hunsaker recommended a
contract purchase at fair market value and that the interest rate be based on a fair market rate.
Mr. Doug West, Department of Human Services, reviewed information in the handout
Utah Valley State College Land Study. He reported that the DSPD Board, the division director, and the superintendent of the Utah State Developmental Center agreed that the college will not
have a negative impact on the developmental center. He believes there is an adequate buffer
between the facility and the proposed campus. Mr. West said it is important to establish fair
market value and a fair rate of return to ensure the highest possible return to the trust lands. The
committee discussed options regarding future use of the property and financing considerations
including long-term lease versus purchase.
Mr. Kent Beirs will forward to the committee a copy of the Department of Facilities
Construction and Management's response to this report.
6. Adjournment--
MOTION: Rep. Davis moved to adjourn the meeting at 4:40 p.m. The motion passed unanimously.